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Answer to Case of the Month #144
Juvenile Dermatomyositis
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bDivision of Rheumatology, Department of Pediatrics, IWK Health Centre, Halifax, Nova Scotia, CanadaClinical Presentation
A previously healthy 5-year-old boy presented with a low-
grade fever, migratory myalgia, and progressive proximal
muscle weakness over a period of 1 month. Physical examina-
tion revealed severe, symmetric weakness of the trunk andFigure 1. Axial T2-weighted image with fat saturation shows diffuse oedema
of pelvic girdle muscles. There is extensive fascial oedema and dermal
thickening with subcutaneous oedema.
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doi:10.1016/j.carj.2009.02.013proximal extremities, multiple joint effusions, and a heliotrope
rash over the right upper eyelid. The white blood cell count and
erythrocyte sedimentation ratewere normal. The serum creatine
kinase level was increased at 7,900 IU/L (normal,<160 IU/L).
A magnetic resonance imaging (MRI) scan was performed with
sedation, and selected images are provided (Figures 1 and 2).Figure 2. Coronal short tau inversion recovery image shows oedema
extending into the proximal thigh muscle groups. Again, there is extensive
fascial and subcutaneous oedema.
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Juvenile dermatomyositis (JDM).
Radiologic Findings
An axial T2-weighted image with fat saturation (Figure 1)
and a coronal short tau inversion recovery image (Figure 2) of
the pelvis show similar findings. All of the visualized muscle
groups of the pelvic girdle and proximal thighs show diffuse
hyperintensity. There is extensive fascial oedema and subcu-
taneous oedema. These imaging findings, combined with the
patient’s age, heliotrope rash, rapidly progressive and
symmetric proximal muscle weakness, and increased serum
creatine kinase level, are consistent with the diagnosis of JDM.
Discussion
The inflammatory myopathies comprise 3 distinct disease
entities: dermatomyositis (DM), polymyositis (PM), and
sporadic inclusion-body myositis [1]. In all age groups, DM
is more common than PM [1]; PM and inclusion-body
myositis rarely are seen in children [1,2]. Based on the most
recent studies, the incidence of JDM in Great Britain and the
United States ranges from 2 to 3 children per million per year
[2]. DM is a systemic disease, with inflammation often
extending beyond skin and muscles [1,2]. This is apparent
more readily with JDM, compared with adult DM [1,2].
The seminal articles by Bohan and Peter [3,4], written more
than 30 years ago, detailed the currently accepted criteria for
the diagnosis and classification of DM and PM. The diagnosis
of DM requires the presence of a characteristic skin rash
(heliotrope rash and Gottron’s papules), along with at least 3 of
the following findings: symmetric proximal muscle weakness
progressing over weeks to months, increase in serum skeletal
muscle enzyme levels, myopathic findings on electromyog-
raphy, and typical findings on muscle biopsy, including
degenerating and regenerating fibers as well as perivascular
inflammation [3,4]. As noted earlier, JDM is a systemic
inflammatory disorder with a wide range of clinical manifes-
tations, including such signs and symptoms as muscle pain
(73%), fever (65%), dysphagia (44%), hoarseness (43%),
abdominal pain (37%), arthritis (35%), soft-tissue calcifica-
tions (23%), and melena (13%), in addition to rash and
weakness [5]. The incidence of skin ulcerations, calcinosis,
and vasculitis is greater in JDM, compared with adult DM [2].
Most importantly, associated malignancies in children with
JDM have been reported rarely [6]. This is unlike adult DM,
which has a 20% to 25% rate of associated neoplasms and is
well recognized as a paraneoplastic syndrome [6].
The diagnosis of JDM can be made with high sensitivity
and specificity (both >92%), using the criteria of Bohan and
Peter [2]. However, many pediatric rheumatologists are
reluctant to perform electromyography or muscle biopsy
because of the invasive nature of these tests and the high
false-negative rate of muscle biopsy early in the disease [2].Even when muscle biopsy is undertaken, patchy disease can
cause falsely negative results owing to sampling errors [2].
Therefore, the full diagnostic criteria often are not met. It has
been suggested recently that magnetic resonance imaging
(MRI) should be added to the list of diagnostic criteria for
JDM [2]. A recent international consensus survey of the
diagnostic criteria for JDM rated typical findings on MRI,
along with muscle biopsy and electromyography, as the most
useful diagnostic criteria after rash, proximal muscle weak-
ness, and increased serum skeletal muscle enzyme levels [7].
Indeed, some investigators have proposed that MRI poten-
tially could replace muscle biopsy in confirming the sus-
pected diagnosis of JDM in many patients [2]. Certainly,
MRI can guide the biopsy and thus increase the diagnostic
yield by showing inflamed muscle groups [2,8].
The advantages of MRI in the diagnosis and definition of
DM relate primarily to its excellent soft-tissue discrimination
and high sensitivity for inflammation [8]. This is enhanced
further by various fat-suppression techniques [8]. Fat-sup-
pressed T2-weighted sequences and short tau inversion
recovery sequences characteristically show a multifocal or
diffuse pattern of muscle hyperintensity, most marked in the
proximal limbs [8]. Dermal thickening and a reticular pattern
of subcutaneous oedema are seen commonly in areas overlying
inflamed muscle groups [8]. Edema can spread along myo-
fascial planes [8]. Mildly prominent lymph nodes also are
seen. Arthritis and panniculitis, if present, can be shown. The
MRI findings of DM at presentation may be mimicked by
infectious myofasciitis [8]. However, the clinical presentation
of DM differs significantly from that of infectious myofascii-
tis. Muscle atrophy and fatty infiltration occur after a long
course of the disease and appear on MRI as decreased muscle
bulk and increased signal intensity, between muscle bundles,
on both T1- and T2-weighted images without fat suppression
[9]. This appearance is nonspecific and difficult to distinguish
from steroid-induced muscle atrophy.
The mainstay of treatment for JDM is prednisone [1,2].
Second-line therapy involves immunosuppressive agents (eg,
methotrexate, cyclosporine) [1,2]. Other treatments showing
possible benefit include intravenous immunoglobulin therapy
and immunomodulatory therapies [1,2]. The prognosis of
children with JDM has improved steadily over the past several
decades [10]. In a cohort of 65 children from 4 Canadian
centers, diagnosed between 1984 and 1995, there was 1 death
[10]. Seventy-two percent of the survivors reported no
disability or minimal disability, and of the 28% with more than
minimal disability, 8% had moderate-to-severe disability [10].
Sixty-three percent of the children had relapsing/remitting or
chronic continuous disease, and 37% had a single disease
episode [10]. None of the children in this cohort developed
a malignancy over a follow-up period ranging from 3 to 14
years [10]. Conventional MRI can be used to assess treatment
response by tracking the disappearance of oedema [8].
Experimental techniques such as phosphorus-31 magnetic
resonance spectroscopy and quantitative assessment of T2
relaxation time have shown promise in the objective assess-
ment of disease activity [11,12].
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primarily involves skin and muscles, but frequently involves
other tissues as well. Unlike adult DM, which has a high
association with malignancy, JDM is typically not a paraneo-
plastic condition. MRI is useful in the diagnosis and follow-up
evaluation of JDM, and it can guide muscle biopsy. MRI,
showing characteristic findings of patchy or diffuse muscle T2
hyperintensity and fascial and subcutaneous oedema, is likely
to become an increasingly important part of the diagnostic
algorithm for children with suspected JDM and may entirely
replace more invasive tests in the future.
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